In 2023, Spain led government expenditure on health R&D in Europe with €1.53 billion, showing a 6.78% increase from the previous year. Italy's 2023 spending was €1.19 billion, reflecting a 4.91% rise. Austria allocated €0.49 billion, marking a substantial 7.17% increase. Greece's spending of €0.18 billion grew by 4.94%. Luxembourg's nominal spending of €0.06 billion increased by 1.0%. Estonia, Latvia, Slovakia, and Lithuania invested smaller amounts, with Latvia showing the highest year-on-year increase of 13.53%. Lithuania's expenditure decreased by 2.81%, contrasting with other positive trends.
Future trends to watch for include:
- Continued investment growth in health R&D, particularly in larger economies like Spain and Italy.
- Potential policy-driven increases in smaller countries, aimed at enhancing their health innovation capabilities.
- The impact of emerging health technologies on R&D funding distributions.
- Geopolitical and economic factors affecting R&D budget allocations.
Top countries in Government Expenditure on R&D in Health by Country
| # | 9 Countries | Million Euros | Last Year | YoY | 5-years CAGR | |
|---|---|---|---|---|---|---|
| 1 | 1 Spain | 1,530 | 2023 | +6.21% | +6.78% | View data |
| 2 | 2 Italy | 1,190 | 2023 | +1.67% | +4.91% | View data |
| 3 | 3 Austria | 491.49 | 2023 | +5.7% | +7.17% | View data |
| 4 | 4 Greece | 183.32 | 2023 | +4.24% | +4.94% | View data |
| 5 | 5 Luxembourg | 62.81 | 2023 | +0.96% | +1% | View data |
| 6 | 6 Estonia | 24.1 | 2023 | +5.02% | +2.36% | View data |
| 7 | 7 Latvia | 18 | 2023 | +7.14% | +13.53% | View data |
| 8 | 8 Slovakia | 12.27 | 2023 | +0.62% | +7.03% | View data |
| 9 | 9 Lithuania | 4.62 | 2023 | +2.37% | -2.81% | View data |
